IBD Flashcards
What are some of the things that treatment choice of IBD is based on?
actual dz (UC vs CD), location, severity, behavior, compliance
MOA of 5-ASA agents?
block cyclooxyrgenase and lipoxygenase-> inhibit prostaglandin
5-ASA (mesalamine and sulfasalazine) is used for ____
mild to moderate UC
Corticosteroids are effective only for _____ in UC and CD
induction, not used for maintenance
Budesonide is a low bioavailability ____ and used for _____ in CD and UC
steroid (good for side effect profile to be low bioavailable)
induction
Budesonide has two formulations: _______ in ileocecal CD and _______ in UC
ileal release formulation
colonic release formulation
Methotrexate MOA
interferes with purine synthesis (folate antagonist)
Methotrexate can be used for _____ in CD but is contraindicated in ____
induction and maintenance (steroid sparing)
pregnancy becasue it is a teratogen
Thiopurines (AZA, 6MP) work at 3 enzymatic pathways. They are:
xanthine oxidase
thiopurine methyltransferase (TPMT)
hypoxanthine phosphoribosyl transferase (HPRT) (towards the active metabolite)
_____ was the first approved anti-TNF agent used for UC and CD. Other ones used now are:
infliximab
Adalimumab, certolizumab, golimumab
Anti-TNF agents have a ___ response and can close ___ in CD. They induce ____ _____
rapid, fistulas, mucosal healing
Ustekinumab (IV then SC) MOA is ____ and can be used in ___
IL-12/23 mAb
CD and UC
Vedolizumab MOA is ____, which is good because it is _____
α4β7 integrin mAb, gut specific
Tofacitinib is an oral medication that is a ___ (MOA) and is used in __
JAK inhibitor, induction and maintenance of UC
Ozanimod is a ________ (MOA) and used in __
Sphingosine-1-phosphate receptor agonist
UC